Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 Administered in Healthy Adolescents.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Prevention
Active
12 to 15
Pharmaceutical / Industry
106636
NCT00534638
2.
Evaluate Safety of a Vaccine Against Cervical Cancer (HPV-16/18 L1/AS04) in Healthy Filipino Females Aged 10 Yrs & Above
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Prevention
Active
10 and over
Pharmaceutical / Industry
108160
NCT00730847
3.
Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Biomarker/Laboratory analysis, Prevention
Active
10 to 25
Pharmaceutical / Industry
106069
NCT00481767
4.
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Prevention
Approved-not yet active
18 and over
Pharmaceutical / Industry
111955
NCT00799825
5.
Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Prevention
Approved-not yet active
25 and over
Pharmaceutical / Industry
111712
NCT00811798
6.
Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in HIV Infected Females
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Prevention
Active
18 to 25
Pharmaceutical / Industry
107863
NCT00586339
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute